Donatella Malanga Selected Research

Donatella Malanga Research Topics

Disease

12	Neoplasms (Cancer) 05/2022 - 06/2007
7	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2017 - 01/2012
3	Thyroid Neoplasms (Thyroid Cancer) 06/2010 - 06/2007
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 06/2006
2	Infections 01/2021 - 01/2016
2	Hyperplasia 01/2019 - 01/2016
2	Colonic Neoplasms (Colon Cancer) 04/2018 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2016 - 06/2007
1	Parkinsonian Disorders (Parkinsonism) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 03/2021
1	COVID-19 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Genomic Instability 01/2018
1	Tics (Tic) 12/2015
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 03/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2008
1	Adenocarcinoma 03/2008
1	Adenoma (Adenomas) 06/2007
1	Virus Diseases (Viral Diseases) 06/2006

Drug/Important Bio-Agent (IBA)

3	Phosphotransferases (Kinase)IBA 04/2018 - 11/2007
3	Messenger RNA (mRNA)IBA 03/2012 - 06/2010
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 11/2007
2	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2017
2	Small Interfering RNA (siRNA)IBA 03/2021 - 12/2015
2	NucleotidesIBA 04/2018 - 03/2008
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2018 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 01/2017 - 03/2008
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017 - 03/2012
2	Cyclin-Dependent Kinase Inhibitor p27IBA 03/2012 - 06/2007
1	Protein CIBA 01/2023
1	Annexin A1IBA 01/2023
1	Cyclin D1IBA 05/2022
1	Polymethyl Methacrylate (Sol)IBA 01/2021
1	3- (4- methylphenylsulfonyl)- 2- propenenitrileIBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	Histone MethyltransferasesIBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2019
1	Proteasome InhibitorsIBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Biomarkers (Surrogate Marker)IBA 04/2018
1	methionylmethionine (Met-Met)IBA 04/2018
1	tyrosine receptor (receptor, tyrosine)IBA 04/2018
1	Excipients (Suspending Agents)IBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2016
1	Urethane (Ethyl Carbamate)IBA 01/2016
1	CarcinogensIBA 01/2016
1	NF-kappa B (NF-kB)IBA 12/2015
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2015
1	Interleukin-6 (Interleukin 6)IBA 12/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2012
1	Tyrosine (L-Tyrosine)FDA Link 03/2012
1	ErbB Receptors (EGF Receptor)IBA 03/2012
1	Protein Tyrosine PhosphatasesIBA 03/2012
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2012
1	PhosphotyrosineIBA 03/2012
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 03/2012
1	RNA (Ribonucleic Acid)IBA 01/2012
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	AgarIBA 09/2009
1	N 30IBA 11/2007
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2007
1	Antisense OligonucleotidesIBA 11/2007
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 06/2007
1	RacivirIBA 06/2007
1	Insulin (Novolin)FDA Link 06/2006
1	Interferon-alpha (Interferon Alfa)IBA 06/2006

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2016
1	Drug Therapy (Chemotherapy) 04/2018